JULIAN
CARRETERO ASUNCION
TITULAR DE UNIVERSIDAD
![Foto de JULIAN](/img/nophoto.png)
![Foto de GlaxoSmithKline (United Kingdom)](/img/noimage_org.png)
GlaxoSmithKline (United Kingdom)
Londres, Reino UnidoPublications in collaboration with researchers from GlaxoSmithKline (United Kingdom) (1)
2012
-
Ganetespib (STA-9090), a nongeldanamycin HSP90 inhibitor, has potent antitumor activity in in vitro and in vivo models of non-small cell lung cancer
Clinical Cancer Research, Vol. 18, Núm. 18, pp. 4973-4985